(Q40484822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Synthetic peptides as diagnostic tools in virology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

Leinikki P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Lehtinen M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Parkkonen P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Kantanen ML

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Hakulinen J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

Advances in Virus Research

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

149-186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7679241%20AND%20SRC:MED&resulttype=core&format=json

Purification by immunoadsorption and immunochemical properties of histone H3.

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Immunochemical studies of tobacco mosaic virus--V. Localization of four epitopes in the protein subunit by inhibition tests with synthetic peptides and cleavage peptides from three strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking of protein binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

A proposal for the nomenclature of antigenic sites in peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The antigenic structure of proteins: a reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Immunochemical studies on the tobacco mosaic virus protein. VI. Characterization of antibody populations following immunization with tobacco mosaic virus protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Intrinsic and extrinsic factors in protein antigenic structure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Chemical characterization of tetanus toxin and toxoid. Amino acid composition, number of SH and S-S groups and N-terminal amino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic peptides as antigens: pitfalls of conjugation methods

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

T-cell antigenic sites tend to be amphipathic structures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Seroconversion to HIV-1 negative regulation factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Random peptide libraries: a source of specific protein binding molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Mapping of linear epitopes of human papillomavirus type 16: The E1, E2, E4, E5, E6 and E7 open reading frames

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Peptides as antigens. Importance of orientation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Post-transfusion hepatitis after open-heart surgery in Finland--a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Three-dimensional structure of membrane and surface proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

A new peptide for human parvovirus B19 antibody detection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibody response in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

A priori delineation of a peptide which mimics a discontinuous antigenic determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Strategies for epitope analysis using peptide synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Chemistry of antibody binding to a protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Genome organization and transactivation of the human immunodeficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Neutralizing Antibodies to Human Rhinovirus Produced in Laboratory Animals and Humans that Recognize a Linear Sequence from VP2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The development and application of protein-liposome conjugation techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Neutralizing epitopes of human parainfluenza virus type 3 are conformational and cannot be imitated by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Protein surface analysis. Methods for identifying antigenic determinants and other interaction sites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Prediction of protein antigenic determinants from amino acid sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The complete nucleotide sequence of coxsackievirus A21.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Complete nucleotide sequence of the genome of coxsackievirus B1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Mobility and evolutionary variability factors in protein antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Dynamics of proteins: elements and function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Autologous Red Cell Agglutination Assay for HIV-1 Antibodies: Simplified Test with Whole Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Demonstration of evolutionary differences between conserved antigenic epitopes in the minor nucleocapsid protein of human papillomavirus types 6b, 16 and 18.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigen attachment in ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Genome of coxsackievirus B3.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Development of Cross-Reactive Antibodies to Plasminogen during the Immune Response to Dengue Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic idiotypes: The third hypervariable region of murine anti-dextran antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Carrier-bound synthetic peptides. Use as antigen in HIV-1 ELISA tests and in antiserum production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Comparison of different methods for localizing antigenic regions in histone H2A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Search for Epitope-Specific Antibody Responses to the Human Immunodeficiency Virus (HIV-1) Envelope Glycoproteins Signifying Resistance to Disease Development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The chemistry of site-directed serology for HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

1 reference

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigenic regions of poliovirus type 3/sabin capsid proteins recognized by human sera in the peptide scanning technique

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Use of synthetic peptides for the detection of antibodies against the nef reguating protein in sera of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Epitope mapping employing immobilized synthetic peptides How specific is the reactivity of these peptides with antiserum raised against the parent protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification of a Linear Epitope on the Fusion Glycoprotein of Respiratory Syncytial Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Prediction of antigenic determinants and secondary structures of the major AIDS virus proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Engineering of site-directed antisera against vertebrate calmodulin by using synthetic peptide immunogens containing an immunoreactive site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

An assessment of prediction methods for locating continuous epitopes in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Nucleotide sequence of the AIDS virus, LAV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Choice of peptide and peptide length for the generation of antibodies reactive with the intact protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Correlation between segmental mobility and the location of antigenic determinants in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

Immunochemical Studies on Tobacco Mosaic Virus Protein. V. The Solid-Phase Synthesis of Peptides of an Antigenically Active Decapeptide of Tobacco Mosaic Virus Protein and the Reaction of These Peptides with Antibodies to the Whole Protein*

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960085-8

7 January 2021

10.1016/S0065-3527(08)60085-8

Identifiers

DOI

0 references

1 reference